Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Imboden AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Hoxie AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Harrisburg AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Grubbs AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Fisher AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Etowah AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Egypt AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Dell AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Delaplaine AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Datto AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.